Clinical Skin Acquires Glytone, Expanding its Footprint in Cosmeceutical Skincare

Clinical Skin Acquires Glytone, Expanding its Footprint in Cosmeceutical Skincare


THE WHAT?  Clinical Skin has acquired Glytone from Pierre Fabre Laboratories, expanding its portfolio in the cosmeceutical skincare industry.

THE DETAILS Glytone is recognized for its dermatological solutions and has a history of clinical efficacy in treating skin concerns such as aging, hyperpigmentation, and acne. This acquisition aligns with Clinical Skin’s commitment to science, innovation, and luxury in skincare.

THE WHY?  Glytone, under Pierre Fabre Laboratories for over 20 years, has developed a reputation for quality and effectiveness, earning the trust of dermatologists and consumers in the United States. Jaime Castle, CEO of Clinical Skin, and Lisa Morris, CEO of Pierre Fabre USA, both expressed their enthusiasm for the merger, emphasizing its potential to enhance product offerings and maintain high standards of quality and customer satisfaction.

WELLNESS

FASHION

TRAVEL

PROFESSIONAL BEAUTY

JOBS & PEOPLE